Potential antitumor phenoxazines
1991; Wiley; Volume: 11; Issue: 3 Linguagem: Inglês
10.1002/med.2610110302
ISSN1098-1128
AutoresNoboru Motohashi, Lester A. Mitscher, Roger Meyer,
Tópico(s)Phenothiazines and Benzothiazines Synthesis and Activities
ResumoMedicinal Research ReviewsVolume 11, Issue 3 p. 239-294 Article Potential antitumor phenoxazines Noboru Motohashi, Corresponding Author Noboru Motohashi Department of Medicinal Chemistry, Meiji College of Pharmacy, 1–22–1, Yato-cho, Tanashi-shi, Tokyo 188, Japan Noboru Motohashi: , Ph.D., is Professor of the Department of Medicinal Chemistry at Meiji College of Pharmacy, Tokyo, Japan. His research interests lie mainly in the field of cancer chemotherapy of phenoxazine and phenothiazines.Department of Medicinal Chemistry, Meiji College of Pharmacy, 1–22–1, Yato-cho, Tanashi-shi, Tokyo 188, JapanSearch for more papers by this authorLester A. Mitscher, Lester A. Mitscher Department of Medicinal Chemistry, The University of Kansas, Lawrence, Kansas 66045–2500 Lester A. Mitscher: , Ph.D., is Kansas University Distinguished Professor and Chairman of the Department of Medicinal Chemistry at The University of Kansas, Lawrence. His main interests in research lie in the field of tetracycline, anthracycline anticancer agents, and quinolone antimicrobial agents.Search for more papers by this authorRoger Meyer, Roger Meyer Herbert Laboratories, 1202E, Wakeham, Santa Ana, California, 92715 Roger Meyer: is Head of the Department of Analytical Chemistry at Herbert Laboratories, Santa Ana, California. His research interests lie mainly in the field of high-performance liquid chromatography on drugs.Search for more papers by this author Noboru Motohashi, Corresponding Author Noboru Motohashi Department of Medicinal Chemistry, Meiji College of Pharmacy, 1–22–1, Yato-cho, Tanashi-shi, Tokyo 188, Japan Noboru Motohashi: , Ph.D., is Professor of the Department of Medicinal Chemistry at Meiji College of Pharmacy, Tokyo, Japan. His research interests lie mainly in the field of cancer chemotherapy of phenoxazine and phenothiazines.Department of Medicinal Chemistry, Meiji College of Pharmacy, 1–22–1, Yato-cho, Tanashi-shi, Tokyo 188, JapanSearch for more papers by this authorLester A. Mitscher, Lester A. Mitscher Department of Medicinal Chemistry, The University of Kansas, Lawrence, Kansas 66045–2500 Lester A. Mitscher: , Ph.D., is Kansas University Distinguished Professor and Chairman of the Department of Medicinal Chemistry at The University of Kansas, Lawrence. His main interests in research lie in the field of tetracycline, anthracycline anticancer agents, and quinolone antimicrobial agents.Search for more papers by this authorRoger Meyer, Roger Meyer Herbert Laboratories, 1202E, Wakeham, Santa Ana, California, 92715 Roger Meyer: is Head of the Department of Analytical Chemistry at Herbert Laboratories, Santa Ana, California. His research interests lie mainly in the field of high-performance liquid chromatography on drugs.Search for more papers by this author First published: May 1991 https://doi.org/10.1002/med.2610110302Citations: 36 AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume11, Issue3May 1991Pages 239-294 RelatedInformation
Referência(s)